Multiple Sclerosis

Group leader

Luisa María Villar Guimerans

luisamaria.villar(ELIMINAR)@salud.madrid.org

Tlf.: 0034 913368029

Principal Investigator

  • Eulalia Rodríguez Martín

Collaborating Staff

  • María Mercedes Espiño Martínez
  • Ernesto Roldán Santiago
  • Lucienne Costa-Frossard França
  • Susana Sainz de la Maza Cantero
  • Enric Monreal Laguillo
  • José Ignacio Fernández Velasco
  • Noelia Villarrubia Migallón
  • Roberto Pariente Rodríguez
  • Alexander Rodero Romero
  • Juan Luis Chico Garcia
  • Fernando Rodríguez Jorge
  • Paula Batres Faba
  • Raquel Sainz Amo
Imagen equipo

Group leader

Luisa María Villar Guimerans

luisamaria.villar(ELIMINAR)@salud.madrid.org

Tlf.: 0034 913368029

Principal Investigator

  • Eulalia Rodríguez Martín

Collaborating Staff

  • María Mercedes Espiño Martínez
  • Ernesto Roldán Santiago
  • Lucienne Costa-Frossard França
  • Susana Sainz de la Maza Cantero
  • Enric Monreal Laguillo
  • José Ignacio Fernández Velasco
  • Noelia Villarrubia Migallón
  • Roberto Pariente Rodríguez
  • Alexander Rodero Romero
  • Juan Luis Chico Garcia
  • Fernando Rodríguez Jorge
  • Paula Batres Faba
  • Raquel Sainz Amo

Strategic Objectives

Our objective is to explore the physiopathological mechanisms of MS, with the aim to identify new therapeutic targets of the disease and contribute to personalised patient treatment.

One of our strategic objectives is the study of the mechanisms associated with the changes that occur in patients with age and the progressive form of the disease, for which there are currently no approved modifying treatments. This is particularly relevant, since age usually brings a lack of gradual response to many of the currently approved MS therapies.

Research Lines

  • Search for biomarkers that identify the best benefit/risk profile for different biologic therapies in MS.
  • Search for biomarkers to identify the risk of progression in MS
  • Immunological mechanisms that are associated with primarily progressive forms of MS.
  • Association of antibodies to Epstein-Barr virus and clinical and immunologic phenotype in MS.
  • Study of the response to vaccines against SARS-CoV-2 in MS.
  • Study of pathological mechanisms in MS.

Location

Laboratory:

Immunology Service. 1st floor left..

Clinical Unit:

Neurology Service: 2nd floor right.          
Ramón y Cajal University Hospital

Keywords

multiple sclerosis (MS), biomarkers, immunological mechanisms, B cells, antibodies.